» Articles » PMID: 22263102

Lung Cancer, Thyroid Cancer or Both: An Unusual Case Presentation

Overview
Journal J Thorac Dis
Specialty Pulmonary Medicine
Date 2012 Jan 21
PMID 22263102
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer metastasis to the thyroid is rare. Primary sites that have been reported to metastasize to the thyroid gland include breast and kidney. There are very few case reports describing metastasis of a lung primary cancer to the thyroid gland. We describe a case of a never-smoker patient with metastatic adenocarcinoma of the lung and a malignant thyroid mass presenting simultaneously. The thyroid biopsy could not distinguish whether it was a metastasis or incidentally found thyroid primary carcinoma. Based on EGFR mutational status it was determined that he has a primary lung cancer and thyroid metastasis. He was started on erlotinib and has had a marked response in both the lung and the thyroid masses. The presence of mutations within the EGFR gene can help distinguish lung adenocarcinoma from other carcinomas like thyroid cancer. This is the first published case of primary lung adenocarcinoma with metastasis to thyroid and with EGFR mutation.

Citing Articles

The Interplay Between Cardiovascular Disease and Lung Cancer.

Katic L, Choi J, Diaz Saravia S, Silverman A, Nagourney A, Torelli V Cureus. 2024; 16(6):e62953.

PMID: 39044884 PMC: 11265258. DOI: 10.7759/cureus.62953.


Thyroid metastasis revealing a lung adenocarcinoma: A case report and review of the literature.

Elouarith I, Benbella L, Arsalan O, El Malki H, Znati K, Jahid A Int J Surg Case Rep. 2022; 98:107525.

PMID: 36055168 PMC: 9482921. DOI: 10.1016/j.ijscr.2022.107525.


Clinicopathological and Molecular Features of Secondary Cancer (Metastasis) to the Thyroid and Advances in Management.

Nguyen M, He G, Lam A Int J Mol Sci. 2022; 23(6).

PMID: 35328664 PMC: 8955551. DOI: 10.3390/ijms23063242.


Thyroid metastasis revealing a lung adenocarcinoma.

Ben Saad A, Mhamed S, Migaou A, Njima M, Achour A, Fahem N Respir Med Case Rep. 2020; 30:101065.

PMID: 32489846 PMC: 7256324. DOI: 10.1016/j.rmcr.2020.101065.


Genomic Profiling Reveals Medullary Thyroid Cancer Misdiagnosed as Lung Cancer.

Gordon E, Parker D, Barth K, Pena J, Elvin J, DeLeon T Case Rep Oncol. 2018; 11(2):399-403.

PMID: 30022943 PMC: 6047557. DOI: 10.1159/000490238.


References
1.
Nakhjavani M, Gharib H, Goellner J, Van Heerden J . Metastasis to the thyroid gland. A report of 43 cases. Cancer. 1997; 79(3):574-8. DOI: 10.1002/(sici)1097-0142(19970201)79:3<574::aid-cncr21>3.0.co;2-#. View

2.
Siegel-Lakhai W, Beijnen J, Schellens J . Current knowledge and future directions of the selective epidermal growth factor receptor inhibitors erlotinib (Tarceva) and gefitinib (Iressa). Oncologist. 2005; 10(8):579-89. DOI: 10.1634/theoncologist.10-8-579. View

3.
Subramanian J, Govindan R . Lung cancer in never smokers: a review. J Clin Oncol. 2007; 25(5):561-70. DOI: 10.1200/JCO.2006.06.8015. View

4.
Pao W, Miller V, Zakowski M, Doherty J, Politi K, Sarkaria I . EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci U S A. 2004; 101(36):13306-11. PMC: 516528. DOI: 10.1073/pnas.0405220101. View

5.
Travis W . Pathology of lung cancer. Clin Chest Med. 2002; 23(1):65-81, viii. DOI: 10.1016/s0272-5231(03)00061-3. View